跳至主要内容
临床试验/NCT03041545
NCT03041545已完成不适用

Tracking Physical Activity Throughout Chemotherapy for Breast Cancer

University of California, San Diego1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2015年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
Recruitment

研究概览

简要总结

Physical activity during chemotherapy has been shown to increase patient health and wellbeing as well as improve outcomes in breast cancer patients. The primary aim of this project is to determine the feasibility of incorporating wearable sensors into clinical care by having breast cancer patients, undergoing chemotherapy, wear a commercially available monitor (Fitbit) that tracks physical activity, sleep, and heart rate monitor.

详细描述

Although there are many benefits of engaging in physical activity during cancer treatments, activity levels typically decline throughout treatment. Existing research has primarily relied on self-reported activity levels and only captured periodic snap shots or retrospective reports of activity levels, which are subject to recall bias. Exactly how activity levels change throughout chemotherapy is not known. This study will provide minute-by-minute level objective physical activity data across the entirety of the patient's chemotherapy treatments. This in depth data will provide a new perspective on the patterns of activity levels and help to identify if there are critical times in which to intervene to prevent declines in physical activity.

The investigators will assess the feasibility of the pre-treatment recruitment by documenting recruitment rates and participant acceptance of wearing the accelerometer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosed with breast cancer
  • Scheduled to receive chemotherapy, but has not yet started chemotherapy
  • Receiving chemotherapy at a University of California, San Diego clinic
  • Willingness to wear the Fitbit throughout the course of chemotherapy
  • Access to a computer or Bluetooth enabled phone to sync Fitbit data
  • Able to read and communicate in English

排除标准

  • Serious physical limitation that greatly limits mobility

结局指标

主要结局

Recruitment

时间窗: 06/01/2015-06/01/2018

Enrolling \>20% of eligible patients

次要结局

  • Retention(From date enrolled into the study until 1 week after the date of the last infusion center visit for chemotherapy, which is typically up to 6 months.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheri Hartman

Assistant Professor

University of California, San Diego

研究点 (1)

Loading locations...

相似试验